Blog

Airbus SE EADSY recently secured a firm order from Saudi Arabian airline Riyadh Air for six of its A350-1000 aircraft, increasing the carrier's total firm commitment for the model to 31 aircraft.The

Zions Bancorporation’s ZION second-quarter 2026 adjusted earnings of $1.74 per share surpassed the Zacks Consensus Estimate of $1.57. Moreover, the bottom line increased 10.1% from the year-ago

Entera Bio ENTX shares have rallied about 34.5% over the past month, driven by investor optimism after the company received positive FDA feedback on the phase III registrational study design for

Moody's MCO is scheduled to announce second-quarter 2026 results on July 22, before the opening bell. The company’s Corporate Finance line, the largest revenue contributor at the Moody's Investors

BOK Financial Corporation's BOKF second-quarter 2026 adjusted earnings of $2.59 per share surpassed the Zacks Consensus Estimate of $2.56. The bottom line jumped 18.3% from the prior-year quarter.

Ameriprise Financial, Inc. AMP is slated to announce second-quarter 2026 results on July 23, before market open. Its quarterly revenues and earnings are expected to have risen year over year.In the

Halozyme Therapeutics HALO announced that it has entered into a global collaboration and license agreement with Incyte INCY to evaluate additional subcutaneous formulations of the latter’s

Teledyne Technologies, Inc. TDY is scheduled to release second-quarter 2026 results on July 22, before market open. The company delivered an earnings surprise of 5.84% in the last reported

The Zacks Utility - Electric Power industry offers a compelling opportunity for stable, long-term income, supported by its regulated business model. Utilities can recover approved costs and earn

Space Exploration Technologies Corporation SPCX made its debut on Wall Street on June 12, 2026, at $135 per share. This was one of the largest public listings in history, making founder Elon Musk

Zacks Investment Research has recently initiated coverage of KVH Industries, Inc. KVHI, assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the company's

Equifax Inc. EFX has reported second-quarter 2026 adjusted earnings of $2.25 per share, up 12.5% year over year. The figure beat the Zacks Consensus Estimate of $2.21 by 1.8%.

Revenues increased

Lamb Weston Holdings, Inc. LW is likely to witness top-line growth when it reports fourth-quarter fiscal 2026 earnings on July 24. The Zacks Consensus Estimate for revenues is pegged at $1.7

Qnity Electronics’ Q Interconnect Solutions (“ICS”) segment focuses on materials used in advanced semiconductor packaging, printed circuit boards, thermal management and electronic interconnects

Crown Holdings, Inc. CCK reported second-quarter 2026 adjusted earnings of $2.49 per share, up 15.8% year over year. The figure surpassed the Zacks Consensus Estimate of $2.15 by 15.81%.Including

Energy stocks have been among the market's strongest performers in 2026, but a handful of smaller companies have delivered gains that far exceed the broader sector. Blue Dolphin Energy Company BDCO

KeyCorp’s KEY second-quarter 2026 earnings from continuing operations of 44 cents per share outpaced the Zacks Consensus Estimate of 42 cents. The bottom line reflected a 25.7% rise from the

Cracker Barrel Old Country Store, Inc. CBRL is taking decisive steps to strengthen its financial position and sharpen focus on the core business. It recently completed a sale-leaseback transaction

General Motors GM reported second-quarter 2026 adjusted earnings of $3.57 per share, up 41.3% year over year. The figure beat the Zacks Consensus Estimate of $3.13 by 14.06%. Better-than-expected

Navitas Semiconductor NVTS is making AI infrastructure the main focus of its business. The company has shifted away from its mobile and low-end consumer business and is now focused on high-power

Mama's Creations, Inc. MAMA is making product innovation an increasingly important part of its growth strategy and the latest quarter highlights that shift. It launched more than a dozen new items

Dyne Therapeutics' DYN shares have gained 19.2% over the past three months, driven by increasing investor confidence in its late-stage neuromuscular disease pipeline. Optimism has been fueled by

MercadoLibre, Inc. MELI continues to deepen its ecosystem integration through its credit card business, which is emerging as a central driver of user engagement. During the first quarter of 2026

Novo Nordisk NVO and Eli Lilly LLY lead the diabetes and obesity market, driven by their blockbuster GLP-1 therapies. Lilly sells its dual GIP/GLP-1 agonist tirzepatide as Mounjaro for type II